• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人去甲肾上腺素转运体整体的结构模型揭示变构位点和配体结合机制。

Structural Models of Human Norepinephrine Transporter Ensemble Reveal the Allosteric Sites and Ligand-Binding Mechanism.

机构信息

Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China.

School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, China.

出版信息

J Phys Chem B. 2024 Sep 12;128(36):8651-8661. doi: 10.1021/acs.jpcb.4c03731. Epub 2024 Aug 29.

DOI:10.1021/acs.jpcb.4c03731
PMID:39207306
Abstract

The norepinephrine transporter (NET) plays a pivotal role in recycling norepinephrine (NE) from the synaptic cleft. However, the structures referring to the conformational heterogeneity of NET during the transport cycle remain poorly understood. Here, three structural models of NE bound to the orthosteric site of NET in outward-open (OO), outward-occluded (OC), and inward-open (IO) conformations were first obtained using the multistate structures of serotonin transporter as templates and further characterized through Gaussian-accelerated molecular dynamics and free energy reweighting. Analysis of the structures revealed eight potential allosteric sites on the functional-specific states of NET. One of the pharmacologically relevant pockets located at the extracellular vestibule was further verified by simulating the binding behaviors of a clinical trial drug χ-MrIA that is allosterically regulating NET. These structural and energetic insights into NET advanced our understanding of NE reuptake and paved the way for discovering novel molecules targeting the allosteric sites.

摘要

去甲肾上腺素转运体(NET)在将去甲肾上腺素(NE)从突触间隙中再循环中起着至关重要的作用。然而,在转运循环过程中,与 NET 构象异质性相关的结构仍知之甚少。在这里,首先使用 5-羟色胺转运体的多态结构作为模板,获得了与 NET 的正位结合的三种结构模型:向外开放(OO)、向外阻塞(OC)和向内开放(IO)构象,然后通过高斯加速分子动力学和自由能再加权进一步进行了特征描述。对结构的分析揭示了 NET 功能特定状态上的八个潜在变构位点。位于细胞外前庭的一个具有药理学相关性的口袋通过模拟临床试验药物 χ-MrIA 的结合行为得到了进一步验证,χ-MrIA 是一种变构调节 NET 的药物。这些关于 NET 的结构和能量的深入了解,促进了我们对 NE 再摄取的理解,并为发现靶向变构位点的新型分子铺平了道路。

相似文献

1
Structural Models of Human Norepinephrine Transporter Ensemble Reveal the Allosteric Sites and Ligand-Binding Mechanism.人去甲肾上腺素转运体整体的结构模型揭示变构位点和配体结合机制。
J Phys Chem B. 2024 Sep 12;128(36):8651-8661. doi: 10.1021/acs.jpcb.4c03731. Epub 2024 Aug 29.
2
Multi-state Model-Based Identification of Cryptic Allosteric Sites on Human Serotonin Transporter.基于多态模型的人血清素转运体隐匿变构部位的鉴定。
ACS Chem Neurosci. 2023 May 3;14(9):1686-1694. doi: 10.1021/acschemneuro.3c00155. Epub 2023 Apr 17.
3
Transport and inhibition mechanisms of the human noradrenaline transporter.人去甲肾上腺素转运体的转运和抑制机制。
Nature. 2024 Aug;632(8026):930-937. doi: 10.1038/s41586-024-07638-z. Epub 2024 Jul 31.
4
Substrate binding and inhibition mechanism of norepinephrine transporter.去甲肾上腺素转运体的底物结合和抑制机制。
Nature. 2024 Sep;633(8029):473-479. doi: 10.1038/s41586-024-07810-5. Epub 2024 Aug 14.
5
Molecular basis of human noradrenaline transporter reuptake and inhibition.人类去甲肾上腺素转运体摄取和抑制的分子基础。
Nature. 2024 Aug;632(8026):921-929. doi: 10.1038/s41586-024-07719-z. Epub 2024 Jul 24.
6
Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking.利用分子模拟和基于集合的配体对接技术研究 SARS-CoV-2 刺突三聚体构象中的结合口袋,以筛选别构抑制剂。
Int J Mol Sci. 2024 May 1;25(9):4955. doi: 10.3390/ijms25094955.
7
A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.第二个细胞外位点是人类去甲肾上腺素转运体摄取去甲肾上腺素所必需的。
Mol Pharmacol. 2012 Nov;82(5):898-909. doi: 10.1124/mol.112.080630. Epub 2012 Aug 8.
8
Putative drug binding conformations of monoamine transporters.单胺转运体的假定药物结合构象。
Bioorg Med Chem. 2006 Feb 1;14(3):666-75. doi: 10.1016/j.bmc.2005.08.054. Epub 2005 Oct 10.
9
Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.基于结构的去甲肾上腺素转运体(NET)相互作用的处方药发现。
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15810-5. doi: 10.1073/pnas.1106030108. Epub 2011 Sep 1.
10
Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.通过分子动力学研究探索已批准的选择性去甲肾上腺素再摄取抑制剂和瑞波西汀对映异构体的抑制机制。
Sci Rep. 2016 May 27;6:26883. doi: 10.1038/srep26883.

引用本文的文献

1
Repurposing drugs for the human dopamine transporter through WHALES descriptors-based virtual screening and bioactivity evaluation.通过基于WHALES描述符的虚拟筛选和生物活性评估将药物用于人类多巴胺转运体
J Pharm Anal. 2025 Aug;15(8):101368. doi: 10.1016/j.jpha.2025.101368. Epub 2025 Jun 14.
2
Molecular docking and molecular dynamics simulations revealed interaction mechanism of acetylcholinesterase with organophosphorus pesticides and their alternatives.分子对接和分子动力学模拟揭示了乙酰胆碱酯酶与有机磷农药及其替代物的相互作用机制。
Arch Toxicol. 2025 Mar 16. doi: 10.1007/s00204-025-04020-4.
3
Identifying Inhibitor-SARS-CoV2-3CL Binding Mechanism Through Molecular Docking, GaMD Simulations, Correlation Network Analysis and MM-GBSA Calculations.
通过分子对接、高斯加速分子动力学(GaMD)模拟、相关网络分析和MM-GBSA计算确定抑制剂与新冠病毒3CL的结合机制
Molecules. 2025 Feb 10;30(4):805. doi: 10.3390/molecules30040805.